BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19908840)

  • 1. Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.
    Jadhav A; Ferreira RS; Klumpp C; Mott BT; Austin CP; Inglese J; Thomas CJ; Maloney DJ; Shoichet BK; Simeonov A
    J Med Chem; 2010 Jan; 53(1):37-51. PubMed ID: 19908840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.
    Mott BT; Ferreira RS; Simeonov A; Jadhav A; Ang KK; Leister W; Shen M; Silveira JT; Doyle PS; Arkin MR; McKerrow JH; Inglese J; Austin CP; Thomas CJ; Shoichet BK; Maloney DJ
    J Med Chem; 2010 Jan; 53(1):52-60. PubMed ID: 19908842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering false positives on a virtual screening search for cruzain inhibitors.
    Malvezzi A; de Rezende L; Izidoro MA; Cezari MH; Juliano L; do Amaral A
    Bioorg Med Chem Lett; 2008 Jan; 18(1):350-4. PubMed ID: 17981033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors.
    Ferreira RS; Simeonov A; Jadhav A; Eidam O; Mott BT; Keiser MJ; McKerrow JH; Maloney DJ; Irwin JJ; Shoichet BK
    J Med Chem; 2010 Jul; 53(13):4891-905. PubMed ID: 20540517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of reversible ketone-Based inhibitors of the cysteine protease cruzain.
    Huang L; Brinen LS; Ellman JA
    Bioorg Med Chem; 2003 Jan; 11(1):21-9. PubMed ID: 12467703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a new class of nonpeptidic inhibitors of cruzain.
    Brak K; Doyle PS; McKerrow JH; Ellman JA
    J Am Chem Soc; 2008 May; 130(20):6404-10. PubMed ID: 18435536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent modes of enzyme inhibition in a homologous structure-activity series.
    Ferreira RS; Bryant C; Ang KK; McKerrow JH; Shoichet BK; Renslo AR
    J Med Chem; 2009 Aug; 52(16):5005-8. PubMed ID: 19637873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain.
    Roush WR; Cheng J; Knapp-Reed B; Alvarez-Hernandez A; McKerrow JH; Hansell E; Engel JC
    Bioorg Med Chem Lett; 2001 Oct; 11(20):2759-62. PubMed ID: 11591518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput identification of promiscuous inhibitors from screening libraries with the use of a thiol-containing fluorescent probe.
    McCallum MM; Nandhikonda P; Temmer JJ; Eyermann C; Simeonov A; Jadhav A; Yasgar A; Maloney D; Arnold AL
    J Biomol Screen; 2013 Jul; 18(6):705-13. PubMed ID: 23446699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2D QSAR and similarity studies on cruzain inhibitors aimed at improving selectivity over cathepsin L.
    Freitas RF; Oprea TI; Montanari CA
    Bioorg Med Chem; 2008 Jan; 16(2):838-53. PubMed ID: 17996450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of reversible inhibitors of IdeS, a bacterial cysteine protease and virulence determinant.
    Berggren K; Johansson B; Fex T; Kihlberg J; Björck L; Luthman K
    Bioorg Med Chem; 2009 May; 17(9):3463-70. PubMed ID: 19362485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-peptidic cruzain inhibitors with trypanocidal activity discovered by virtual screening and in vitro assay.
    Wiggers HJ; Rocha JR; Fernandes WB; Sesti-Costa R; Carneiro ZA; Cheleski J; da Silva AB; Juliano L; Cezari MH; Silva JS; McKerrow JH; Montanari CA
    PLoS Negl Trop Dis; 2013; 7(8):e2370. PubMed ID: 23991231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Potent, Reversible, and Competitive Cruzain Inhibitors with Trypanocidal Activity: A Structure-Based Drug Design Approach.
    de Souza ML; de Oliveira Rezende Junior C; Ferreira RS; Espinoza Chávez RM; Ferreira LLG; Slafer BW; Magalhães LG; Krogh R; Oliva G; Cruz FC; Dias LC; Andricopulo AD
    J Chem Inf Model; 2020 Feb; 60(2):1028-1041. PubMed ID: 31765144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor.
    Ribeiro JFR; Cianni L; Li C; Warwick TG; de Vita D; Rosini F; Dos Reis Rocho F; Martins FCP; Kenny PW; Lameira J; Leitão A; Emsley J; Montanari CA
    Bioorg Med Chem; 2020 Nov; 28(22):115743. PubMed ID: 33038787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cysteine proteases by a natural biflavone: behavioral evaluation of fukugetin as papain and cruzain inhibitor.
    Assis DM; Gontijo VS; de Oliveira Pereira I; Santos JA; Camps I; Nagem TJ; Ellena J; Izidoro MA; dos Santos Tersariol IL; de Barros NM; Doriguetto AC; dos Santos MH; Juliano MA
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):661-70. PubMed ID: 22468751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.
    Braga SF; Martins LC; da Silva EB; Sales Júnior PA; Murta SM; Romanha AJ; Soh WT; Brandstetter H; Ferreira RS; de Oliveira RB
    Bioorg Med Chem; 2017 Mar; 25(6):1889-1900. PubMed ID: 28215783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of quinoline derivatives as potential cysteine protease inhibitors.
    Andrade MM; Martins LC; Marques GV; Silva CA; Faria G; Caldas S; Dos Santos JS; Leclercq SY; Maltarollo VG; Ferreira RS; Oliveira RB
    Future Med Chem; 2020 Apr; 12(7):571-581. PubMed ID: 32116030
    [No Abstract]   [Full Text] [Related]  

  • 20. Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase.
    Babaoglu K; Simeonov A; Irwin JJ; Nelson ME; Feng B; Thomas CJ; Cancian L; Costi MP; Maltby DA; Jadhav A; Inglese J; Austin CP; Shoichet BK
    J Med Chem; 2008 Apr; 51(8):2502-11. PubMed ID: 18333608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.